Sodium Picosulfate
Brand names: Picolax, Dulcolax (oral drops)
Sodium picosulfate is a stimulant laxative used in the surgical and endoscopic setting as oral bowel preparation to empty the colon before colonoscopy, colorectal surgery or imaging; UK products combine it with magnesium citrate.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
After colonic bacteria cleave it to its active form, it stimulates the mucosa to increase peristalsis, while the magnesium citrate component acts osmotically to draw fluid into the bowel lumen, together producing a watery evacuation.
Prescribing in practice
- It causes large fluid and electrolyte shifts that can precipitate dehydration, hyponatraemia, hypokalaemia and acute kidney injury, so ensure generous clear-fluid intake and use great caution in the elderly, renally or cardiac impaired and those on diuretics, ACE inhibitors, ARBs or NSAIDs.
- Contraindicated in suspected intestinal obstruction or perforation, ileus, toxic megacolon, severe inflammatory bowel disease and significant heart failure or renal impairment.
- Separate the timing of other essential oral medicines, as rapid bowel transit can impair their absorption and reduce their effect.
Monitoring
Assess hydration and, where clinically indicated in at-risk patients, check renal function and electrolytes around the preparation period.
Counselling the patient
- Drink plenty of clear fluids throughout the preparation to avoid becoming dehydrated.
- Expect frequent watery diarrhoea and stay near a toilet once you start.
- Seek urgent advice if you develop severe headache, confusion, marked weakness or stop passing urine.
Evidence & guidelines
Sodium picosulfate with magnesium citrate is a standard, evidence-based bowel-cleansing regimen used across UK endoscopy and surgical units.
Reference: Picolax SPC; NICE CG99 (Colorectal Surgery); BSG Bowel Preparation Guidelines; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- DOAC Score for Selecting Direct Oral Anticoagulant in Non-Valvular AF · Anticoagulation
- Corrected Sodium (Hyperglycaemia) · Electrolytes
- Hyponatraemia Cause Algorithm · Electrolyte Disorders
- MELD-Na Score · Liver Disease
- Harvey-Bradshaw Index for Crohn's Disease · Inflammatory Bowel Disease
- Mayo Score for Ulcerative Colitis Activity · Inflammatory Bowel Disease
- Major Trauma — Primary Survey (ATLS) · ATLS 10th Edition; JRCALC; NICE NG39
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Burns — TBSA Estimation & Fluid Resuscitation · British Burn Association; EMSB; RCEM 2024
- Lower Gastrointestinal Bleed · NICE; BSG; ACPGBI — Commissioning Guide
- Acute Pancreatitis · NICE; IAP/APA; ACPGBI — CG104
- Hypertrophic Pyloric Stenosis · BAPS / RCPCH